Using reminders and self-sampling to boost cervical cancer screening participation
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
NA · Karolinska Institutet · NCT04061967
This study is testing if sending text reminders and using self-sampling kits can help women at high risk for cervical cancer get screened more often.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20000 (estimated) |
| Ages | 33 Years to 75 Years |
| Sex | Female |
| Sponsor | Karolinska Institutet (other) |
| Locations | 6 sites (Luleå, Norrbotten County and 5 other locations) |
| Trial ID | NCT04061967 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance participation in cervical cancer screening by utilizing SMS reminders and electronic letters instead of traditional physical mail. The study targets women at high risk for cervical cancer who have not adequately participated in screening programs. By offering self-sampling kits for HPV testing, the study seeks to reduce barriers to screening and improve follow-up care for women with abnormal results. Women are identified through registry linkages that assess their screening history and risk status, and those who qualify will receive invitations to participate.
Who should consider this trial
Good fit: Ideal candidates for this study are women residing in Region Skåne who have not participated in cervical screening for an extended period or have had abnormal results that were not followed up.
Not a fit: Patients who have consistently participated in cervical cancer screening or do not consent to the study will not benefit from this intervention.
Why it matters
Potential benefit: If successful, this approach could significantly increase cervical cancer screening rates and reduce the incidence of cervical cancer among women.
How similar studies have performed: Previous studies have shown that self-sampling and reminder systems can effectively increase participation in cervical cancer screening, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women resident in Region Skane who either: 1) have had glandular cell transformation that has not been followed-up, 2) are older than 65 years and have had cell transformation that has not been followed-up or who have not participated in screening during the last 10 years, 3) women who have not been screened for more than 15 years. Exclusion Criteria: * No exclusion except those who do not consent.
Where this trial is running
Luleå, Norrbotten County and 5 other locations
- Northern Region — Luleå, Norrbotten County, Sweden (RECRUITING)
- Southern Region — Lund, Skåne County, Sweden (RECRUITING)
- Western Region — Gothenburg, Västra Götaland County, Sweden (RECRUITING)
- Southeast Region — Jönköping, Sweden (RECRUITING)
- Region of Stockholm-Gotland — Stockholm, Sweden (RECRUITING)
- Region of Middle Sweden — Uppsala, Sweden (RECRUITING)
Study contacts
- Principal investigator: Miriam Elfström, PhD — Karolinska Institutet
- Study coordinator: Miriam Elfström, PhD
- Email: Miriam.elfstrom@sll.se
- Phone: +46(0)703816277
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cervical Cancer, Uterine Cervical Neoplasm, Uterine Neoplasms, Genital Neoplasm, Genital Neoplasm, Female, Uterine Diseases, Genital Diseases, Female, Neoplasms by Site